Pharmaceutical Commerce - April 2024

Click the title above for a link to open the Pharmaceutical Commerce April 2024 issue in an interactive PDF format.

An exploration of the new demands in cold-chain visibility and sustainability—and the resulting tech-driven efforts to address them—leads off our coverage in this month's issue.

We'll be back in Lyon, France, this month to capture the latest insights and advances in pharma logistics—as leaders seek to build the supply chains of the future.

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.

Why manufacturers should leverage technology to address low adherence rates.

Syneos Health's Kim Plesnarski uncovers the key issues that customers are currently trying to address, including the retail shift from small-molecule products to biologics.

Patients should not have to wait to access the medication they need.

Fighting for patient affordability doesn’t necessarily require a scapegoat.

Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).

A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.

Navigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag.

With its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain.